Abstract
TUMOUR–HOST relationships are determined by many variables1,2, and may be altered to favour the host by the use of chemically modified cells which act as specific immunostimulants3. Furthermore, modified cells have therapeutic value in mice with small tumours4,5. Several studies have shown that conventional methods followed by administration of immunostimulants are very effective in treating tumours and inducing tumour-specific immunity6–8. Combined chemotherapy and immunotherapy of L1210 leukaemia with neuraminidase-treated (VCN) tumour cells yielded a higher percentage of long term survivors than did chemotherapy alone6,7,9,10. The therapeutic effectiveness of VCN-treated cells depended on several variables10, including proper selection of immunogenic cells7,11.
Similar content being viewed by others
References
Hersh, E. M., Gutterman, J. U., and Mavligit, G., in Immunotherapy of Cancer in Man (Thomas, Springfield, Illinois, 1973).
Holmes, E. C., Eilber, F. R., and Morton, D. L., J. Am. med. Ass., 232, 1052–1055 (1975).
Simmons, R. L., and Rios, A., Science, 174, 591–593 (1971).
Rios, A., and Simmons, R. L., Int. J. Cancer, 13, 71–81 (1974).
Simmons, R. L., and Rios, A., Israel J. med. Sci., 10, 925–938 (1974).
Holland, J. F., Cancer Res., 31, 1319–1329 (1971).
Kollmorgen, G. M., et al., Ann. Okla. Acad. Sci., 3, 25–33 (1973).
Song, C. W., et al., Radiat. Res., 59, 168a (1974).
Kollmorgen, G. M., et al. in The Cell Cycle and Malignancy (US ERDA Symposia, 1974).
Kollmorgen, G. M., et al. in Neoplasm Immunity: Theory and Application (University of Illinois Press, 1974).
LeFever, A. V., et al., In Vitro, 10, 388a (1975).
Weston, P. D., and Avrameas, S., Biochem. biophys. Res. Commun., 45, 1574–1580 (1971).
Goldstein, I. J., Hollerman, C. E., and Smith, E. E., Biochemistry, 4, 876–883 (1965).
Kaliss, N., Transplantation, 8, 526–530 (1969).
Hughes, R. C., Palmer, P. D., and Sanford, B. H., J. Immun., 111, 1071–1080 (1973).
Rogentine, G. N., and Plocinik, B. A., J. Immun., 113, 848–858 (1974).
Edelman, G. M., Rutishauser, U., and Millette, C. F., Proc. natn. Acad. Sci. U.S.A., 68, 2153–2157 (1971).
Rutishauser, U., and Edelman, G. M., Proc. natn. Acad. Sci. U.S.A., 69, 3774–3778 (1972).
Rutishauser, U., Millette, C. F., and Edelman, G. M., Proc. natn. Acad. Sci. U.S.A., 69, 1596–1600 (1972).
Ishidate, M., Aoshima, M., and Sakurai, Y., J. natn. Cancer Inst., 53, 773–781 (1974).
Kessel, D., and Bosmann, H. B., Cancer Res., 30, 2695–2701 (1970).
Imbert, I., Barra, Y., and Berebbi, M., J. Cell Sci., 18, 67–77 (1975).
Franks, D., and Dawson, A., Expl Cell Res., 42, 543–561 (1966).
Cikes, M., Friberg, S., and Klein, G., J. natn. Cancer Inst., 49, 1607–1611 (1972).
Nicolson, G. L., and Winkelhake, J. L., Nature, 255, 230–232 (1975).
Hagmar, B., and Norrby, K., Int. J. Cancer, 11, 663–675 (1973).
Weiss, L., Glaves, D., and White, D. A., Int. J. Cancer, 13, 850–862 (1974).
Bosmann, H. B., et al., Nature, 246, 487–489 (1973).
Fidler, I. J., Cancer Res., 35, 218–224 (1975).
Gasic, F. J., et al., Int. J. Cancer, 11, 704–718 (1973).
Kollmorgen, G. M., Bundren, J. C., and Killion, J. J., In Vitro, 8, 259a (1973).
Bonmasser, E., et al., Proc. natn. Acad. Sci. U.S.A., 4, 1089–1095 (1970).
Parks, R. C., J. natn. Cancer Inst., 54, 1473–1474 (1975).
Calman, N. S., et al., J. natn. Cancer Inst., 52, 997–998 (1974).
Boetcher, D. A., and Leonard, E. J., J. natn. Cancer Inst., 52, 1091–1099 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
KILLION, J., KOLLMORGEN, G. Isolation of immunogenic tumour cells by cell-affinity chromatography. Nature 259, 674–676 (1976). https://doi.org/10.1038/259674a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/259674a0
- Springer Nature Limited
This article is cited by
-
Organ specific metastasis with special reference to avian systems
CANCER AND METASTASIS REVIEW (1983)
-
The selective nature of metastasis
CANCER AND METASTASIS REVIEW (1983)
-
Intratumor immunologic heterogeneity
Cancer and Metastasis Reviews (1982)